louisiana semaglutide digestive blockage law firm lawyer semaglutide digestive blockage attorney in louisiana kentucky semaglutide gastrointestinal obstruction lawyer Louisiana Wegovy Lawsuit Lawyer glp-1 diarrhea attorney at law

May 16 Product: Amgens Imdelltra Indication: Small cell lung cancer Amgen secured approval Thursday for its first-in-class bi-specific T-cell engager, Imdelltra, for extensive-stage small cell lung cancer (SCLC)

In the Phase 2 trial, the most common side effects were gastrointestinal, the same pattern seen with semaglutide and tirzepatide

[Editors note: as of this writing, there are no generic version of either semaglutide or tirzepatide approved by the FDA] Understanding Tirzepatide Tirzepatide represents a significant advancement in weight loss medication, uniquely mimicking two of the bodys natural hormones

Starting at lower doses and increasing more slowly often produces better long-term compliance with fewer side effects

Buyer Takeaway: The compounded GLP-1 market is in a period of significant regulatory transition as of June 2026

If you are not sure if you may be affected by any of these conditions, dont worry